CEO Remuneration Report FY21

Wexford Hayes guide to CEO remuneration for the ASX-listed healthcare and biotechnology sectors is out now. Click on the attached link for some key insights. If interested in a copy please contact us.

CEO Rem Report

Previous
Previous

Board Remuneration Report FY21

Next
Next

Do you have what it takes to be a Chief Executive in a COVID world?